In 2023, male mortality for trachea, bronchus, or lung malignant neoplasms in Germany stood at 65.9 deaths per hundred thousand men. Forecasts from 2024 to 2028 predict a gradual decline in the mortality rate, decreasing each year by approximately 0.3% to 0.4%. Specifically, the mortality rate is expected to drop from 65.7 in 2024 to 65.0 in 2028, reflecting a decrease in cases.
Future trends to watch for:
- Advancements in early detection and treatment strategies that could accelerate the decline in mortality rates.
- Policy interventions focusing on smoking cessation and environmental factors that may impact long-term trends in lung cancer mortality.
- Further improvements in healthcare access and personalized medicine approaches that could influence the trajectory of mortality rates.